ViiV, Pfizer and Roche lead list for pharma reputation ranked by patient group, annual survey finds

Patient groups' view of the pharma industry around the world is improving, according to an annual survey published on Tuesday. Fifty-nine percent of patient groups agreed that the pharma industry's corporate reputation is "excellent" or "good," compared to just 50% the year before, according to PatientView's annual online corporate reputation survey.